Needham & Company LLC Cuts Cooper Companies (NASDAQ:COO) Price Target to $99.00

Cooper Companies (NASDAQ:COO) had its price objective trimmed by Needham & Company LLC from $100.00 to $99.00 in a research note released on Tuesday morning, MarketBeat reports. The brokerage currently has a buy rating on the medical device company’s stock.

COO has been the subject of a number of other reports. William Blair upgraded shares of Cooper Companies to a “strong-buy” rating in a report on Friday, January 30th. Piper Sandler restated an “overweight” rating and issued a $94.00 target price (up from $83.00) on shares of Cooper Companies in a research note on Friday, December 5th. The Goldman Sachs Group reaffirmed a “sell” rating and set a $73.00 price target on shares of Cooper Companies in a research note on Friday, January 9th. Robert W. Baird increased their price target on Cooper Companies from $85.00 to $98.00 and gave the stock an “outperform” rating in a report on Friday, December 5th. Finally, KeyCorp restated a “sector weight” rating on shares of Cooper Companies in a report on Friday, December 5th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $90.77.

Cooper Companies Stock Down 1.0%

Shares of NASDAQ:COO opened at $80.10 on Tuesday. Cooper Companies has a 1 year low of $61.78 and a 1 year high of $96.78. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.89 and a quick ratio of 1.13. The business’s 50-day moving average is $81.29 and its 200-day moving average is $74.44. The company has a market capitalization of $15.70 billion, a price-to-earnings ratio of 42.61, a P/E/G ratio of 2.31 and a beta of 1.03.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, December 4th. The medical device company reported $1.15 earnings per share for the quarter, topping analysts’ consensus estimates of $1.11 by $0.04. The business had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a return on equity of 10.02% and a net margin of 9.16%.The firm’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same period in the previous year, the company posted $1.04 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. Equities research analysts predict that Cooper Companies will post 3.98 earnings per share for the current year.

Insider Buying and Selling at Cooper Companies

In related news, Director Lawrence Erik Kurzius acquired 2,000 shares of the company’s stock in a transaction on Wednesday, December 17th. The shares were acquired at an average cost of $82.50 per share, for a total transaction of $165,000.00. Following the purchase, the director owned 7,777 shares in the company, valued at approximately $641,602.50. The trade was a 34.62% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Cynthia L. Lucchese bought 1,784 shares of Cooper Companies stock in a transaction dated Monday, December 22nd. The stock was purchased at an average price of $84.06 per share, with a total value of $149,963.04. Following the purchase, the director owned 9,445 shares in the company, valued at approximately $793,946.70. This represents a 23.29% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders have purchased a total of 16,014 shares of company stock valued at $1,304,416 in the last three months. Insiders own 1.98% of the company’s stock.

Hedge Funds Weigh In On Cooper Companies

Institutional investors have recently added to or reduced their stakes in the stock. Bell Investment Advisors Inc raised its position in Cooper Companies by 106.3% in the third quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock worth $29,000 after acquiring an additional 219 shares during the period. J.Safra Asset Management Corp raised its holdings in shares of Cooper Companies by 204.8% in the 2nd quarter. J.Safra Asset Management Corp now owns 506 shares of the medical device company’s stock worth $36,000 after purchasing an additional 340 shares during the period. CYBER HORNET ETFs LLC purchased a new position in Cooper Companies in the second quarter valued at approximately $36,000. True Wealth Design LLC grew its holdings in Cooper Companies by 484.8% during the fourth quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock valued at $38,000 after purchasing an additional 383 shares during the period. Finally, Cromwell Holdings LLC increased its position in Cooper Companies by 128.8% in the fourth quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock worth $40,000 after buying an additional 273 shares during the last quarter. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.